LDI
Cross-posted from Penn LDI’s Blog By Megan McCarthy-Alfano Screening tools for autism spectrum disorder (ASD) often fail to identify ASD among children from low-income families and racial/ethnic minority groups, particularly when English is not the family’s primary language. A new visually-based tool may reduce these disparities at a pivotal point in children’s development. In Pediatrics, Zuleyha Cidav, David Mandell, and […]
Cross-posted from Penn LDI’s Blog Rebecca Stewart, PhD The opioid epidemic is in its fourth and possibly deadliest wave, exacerbated by the COVID-19 pandemic and disproportionately killing people of color. Medications for opioid use disorder (MOUD)—including methadone, buprenorphine, and naltrexone—are effective in combatting the epidemic, but sorely underused. Philadelphia’s Department of Behavioral Health and Intellectual disability Services (DBHIDS) recently enacted […]
Molly Candon, PhD The U.S. Department of Health and Human Services (HHS) overturned their longstanding requirement that physicians must receive approval and undergo training to prescribe buprenorphine, the topline treatment for opioid use disorder (OUD). This is an historic shift in policy, and its importance cannot be overstated. Last week, there were fewer than 100,000 waivered providers. Now, over one […]